Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Bioorg Med Chem Lett. 2012 Jul 3;22(16):5190–5194. doi: 10.1016/j.bmcl.2012.06.080

Figure 3. BVM-resistant HIV-1 variants were more sensitive to BA entry inhibitors.

Figure 3

Inhibition of HIV-1 infection was measured as the reduction in luciferase gene expression in TZM-bl cells after a single round of virus infection as described previously (15). The bevirimat sensitive virus HIV-1 NL4-3 (solid lines) and resistant virus NL4-3 V370A (dashed lines) were used in this assay. Control: HIV-1 NL4-3 or HIV-1 V370A infection, expressed as relative fluorescence units, in the absence of the compounds.